Combination of Chemotherapy and Gefitinib as First-line Treatment
NCT02148380
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
121
Enrollment
OTHER
Sponsor class
Conditions
Non-Small-Cell Lung Cancer
Interventions
DRUG:
pemetrexed plus carboplatin
DRUG:
gefitinib
Sponsor
Baohui Han